# Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion

Study · id `cardio:ct-nct03473015` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03473015](<https://clinicaltrials.gov/study/NCT03473015>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03473015

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT03473015. Non-randomized; no masking; primary purpose treatment. Start 2015-07-01 (actual); primary completion 2020-10-31 (actual). Results posted on 2023-11-14.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Started: 2015-07-01 (actual) (ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Primary completion: 2020-10-31 (actual) (ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Completion: 2020-10-31 (actual) (ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Results first posted: 2023-11-14 (ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT03473015, source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03473015-2023-11-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion
- Acronym: OxAMI-PICSO
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): PICSO
- Lead sponsor: Oxford University Hospitals NHS Trust
- Lead sponsor class: OTHER
- Collaborator: Miracor Medical SA
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Oxford University Hospitals NHS Trust (`cardio:org-oxford-university-hospitals-nhs-trust`)

## Provenance

Content hash: 65ff5252cd99f72f738f653ce9256e26e591a6fefd48c421b88bcb513ae989c6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
